Retroprosthetic Membranes in AlphaCor Patients: Risk Factors and Prevention

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Cornea

• Publication date

  2005-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/01.ico.0000154380.13237.eaPMID 16015088
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Melting after Keratoprosthesis Implantation: The Effects of Medroxyprogesterone

  2003cited by this paper
• Corneal replacement using a synthetic hydrogel cornea, AlphaCor™: device, preliminary outcomes and complications

  2003cited by this paper
• Indications and Technique: AlphaCor™ Artificial Cornea

  2003cited by this paper
• Histopathology of Explanted Collar Button Keratoprostheses: A Clinicopathologic Correlation

  2003cited by this paper
• Effects of dexamethasone, diclofenac, or placebo on the inflammatory response after cataract surgery

  2002cited by this paper
• The Chirila Keratoprosthesis: phase I human clinical trial.

  2002cited by this paper
• Intracameral tissue plasminogen activator use in a large series of eyes with valved glaucoma drainage implants.

  2002cited by this paper
• Management of vitreoretinal complications in eyes with permanent keratoprosthesis.

  2002cited by this paper
• Seoul-type keratoprosthesis: preliminary results of the first 7 human cases.

  2002cited by this paper
• The Type II Aachen-Keratoprosthesis in Humans: Case Report of the First Prolonged Application

  2001cited by this paper
• Control of intra-ocular inflammation associated with cataract surgery

  2001cited by this paper
• Connective Tissue Growth Factor in Retrocorneal Membranes and Corneal Scars

  2000cited by this paper
• Argatroban inhibits intraocular fibrin formation after vitrectomy in rabbits.

  2000cited by this paper
• Development and clinical assessment of an artificial cornea.

  2000cited by this paper
• Control of intraocular inflammation associated with cataract surgery.

  2000cited by this paper
• Recombinant tissue plasminogen activator following paediatric cataract surgery

  2000cited by this paper
• Comparison of the levels of hepatocyte growth factor and vascular endothelial growth factor in aqueous fluid and serum with grades of retinopathy in patients with diabetes mellitus

  1999cited by this paper
• Ketorolac tromethamine 0.5% ophthalmic solution in the treatment of moderate to severe ocular inflammation after cataract surgery: a randomized, vehicle-controlled clinical trial.

  1999cited by this paper
• [Eye with implanted keratoprosthesis in ultrasound biomicroscopy].

  1999cited by this paper
• The “Aachen” keratoprosthesis: A New Approach towards Successful Keratoprosthesis-Surgery

  1998cited by this paper
• Recombinant tissue plasminogen activator in cases with fibrin formation after cataract surgery: a prospective randomised multicentre study

  1998cited by this paper
• Characterization of fibrous retrocorneal membrane by confocal microscopy.

  1998cited by this paper
• Intraocular and extraocular bleeding after intracameral injection of tissue plasminogen activator

  1998cited by this paper
• Clinical results of implantation of the Chirila keratoprosthesis in rabbits

  1998cited by this paper
• A second generation of artificial cornea (Biokpro II).

  1998cited by this paper
• [Use of Nd:YAG laser for disruption of retrocorneal membranes in eyes with implanted keratoprosthesis].

  1997cited by this paper
• Intracameral tissue plasminogen activator after glaucoma surgery. Indications, effectiveness, and complications.

  1996cited by this paper
• [Complication of keratoprosthesis of posterior fixation: retroprosthetic membranes. Apropos of 4 cases].

  1995cited by this paper
• Keratoprosthesis with biocolonizable microporous fluorocarbon haptic. Preliminary results in a 24-patient study.

  1995cited by this paper
• Interpenetrating polymer network (IPN) as a permanent joint between the elements of a new type of artificial cornea.

  1994cited by this paper
• Intraocular tissue plasminogen activator concentrations after subconjunctival delivery.

  1993cited by this paper
• Effects of cycloplegia and iris pigmentation on postoperative intraocular inflammation.

  1993cited by this paper
• Treatment of anterior chamber fibrin following cataract surgery with tissue plasminogen activator

  1993cited by this paper
• Inhibition of intraocular fibrin formation following infusion of low-molecular-weight heparin during vitrectomy.

  1991cited by this paper
• Intracameral tissue plasminogen activator for treatment of excessive fibrin response after penetrating keratoplasty.

  1990cited by this paper
• Tissue plasminogen activator for postvitrectomy fibrin formation.

  1990cited by this paper
• Risk factors for postvitrectomy fibrin formation.

  1990cited by this paper
• Treatment of postvitrectomy fibrin formation with intraocular tissue plasminogen activator.

  1988cited by this paper
• A prospective, randomized, clinical trial of heparin therapy for postoperative intraocular fibrin.

  1988cited by this paper
• Heparin prophylaxis for intraocular fibrin.

  1987cited by this paper
• Photometric evaluation of YAG-induced polymethylmethacrylate damage in a keratoprosthesis.

  1985cited by this paper
• Fibrinoid syndrome: a severe complication of vitrectomy surgery in diabetics.

  1982cited by this paper
• Keratoprosthesis. Results, complications, and management.

  1982cited by this paper
• Fibrinoid syndrome: a severe complication of vitrectomy surgery in diabetics.

  1982cited by this paper
• FINE STRUCTURE AND COLLAGEN SYNTHESIS ACTIVITY OF MONOLAYER CULTURES OF RABBIT CORNEAL ENDOTHELIUM

  1974cited by this paper

• Mihe (MIOK) KPro with auricular cartilage reinforcement in end-stage corneal blindness: An open-label, nonrandomized trial

  2026cites this paper
• Short-term Evaluation of Efficacy and Biocompatibility of Artificial Corneal Transplantation in Rabbit Model

  2022cites this paper
• Biointegration

  2020cites this paper
• Surgical and Nonsurgical Trauma

  2020cites this paper
• Activation of dendritic cells by crosslinked collagen hydrogels (artificial corneas) varies with their composition

  2019influential citation
• Mesenchymal stem cell therapy for retro-corneal membrane - A clinical challenge in full-thickness transplantation of biosynthetic corneal equivalents.

  2017cites this paper
• Clinical Outcomes Using Oversized Back Plates in Type I Boston Keratoprosthesis

  2017cites this paper
• The development and results of an artificial cornea: AlphaCor™

  2016cites this paper
• Retroprosthetic Membrane Formation After Boston Keratoprosthesis: Is It Truly a Benign Complication?

  2016cites this paper
• Vitreoretinal aspects of permanent keratoprosthesis.

  2015cites this paper
• T-style keratoprosthesis based on surface-modified poly (2-hydroxyethyl methacrylate) hydrogel for cornea repairs.

  2015cites this paper
• AlphaCor: Indications, Contraindications, Techniques and Outcomes

  2015cites this paper
• Fyodorov–Zuev Keratoprosthesis

  2015cites this paper
• Biocompatibility of poly(ethylene glycol) and poly(acrylic acid) interpenetrating network hydrogel by intrastromal implantation in rabbit cornea.

  2015cites this paper
• Keratoconus: Tissue Engineering and Biomaterials

  2014cites this paper
• Capítulo 25 – Queratoplastias

  2014cites this paper
• Histopathological and immunohistochemical analysis of melt-associated retroprosthetic membranes in the Boston type 1 keratoprosthesis.

  2014cites this paper
• C – Corneal Inlays and Onlays

  2013cites this paper
• Wound Anatomy After Type 1 Boston KPro Using Oversized Back Plates

  2013cites this paper
• La kératoprothèse Alphacor™ : dispositif, technique chirurgicale et résultats cliniques

  2013cites this paper
• [Alphacor keratoprosthesis: device, surgical technique and clinical outcomes].

  2013cites this paper
• Risk factors for the development of retroprosthetic membranes with Boston keratoprosthesis type 1: multicenter study results.

  2012cites this paper
• Outcomes of the Boston Keratoprosthesis in Jordan

  2012cites this paper
• Boston type I keratoprosthesis: Review.

  2012cites this paper
• Boston type I keratoprosthesis. Review Ceratoprótese de Boston tipo I. Revisão

  2012cites this paper
• Histologic evaluation of AlphaCor keratoprosthesis explanted following various complications.

  2012cites this paper
• AlphaCor artificial cornea: clinical outcome

  2011cites this paper
• Moscow eye microsurgery complex in Russia keratoprosthesis in Beijing.

  2011cites this paper
• A Matrix of Pathologic Responses in the Cornea

  2011cites this paper
• A Safe Nd:YAG Retroprosthetic Membrane Removal Technique for Keratoprosthesis

  2010cites this paper
• The Boston Keratoprosthesis in 2 Patients With Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy

  2010cites this paper
• Fyodorov–Zuev keratoprosthesis implantation: long-term results in patients with multiple failed corneal grafts

  2010cites this paper
• Keratoprosthesis with retrocorneal fixation: preliminary results in dogs with corneal blindness.

  2010cites this paper
• Boston Type 1 Keratoprosthesis: The University of California Davis Experience

  2009cites this paper
• AlphaCor™ keratoprosthesis: postoperative development of six patients

  2009cites this paper
• The Boston type I keratoprosthesis: improving outcomes and expanding indications.

  2009cites this paper
• Development of Hydrogel‐Based Keratoprostheses: A Materials Perspective

  2008cites this paper
• The Boston keratoprosthesis in Stevens-Johnson syndrome.

  2008cites this paper
• Keratoprosthesis surgery.

  2008cites this paper
• Clinicopathologic Correlation of Explanted AlphaCor Artificial Cornea After Exposure of Implant

  2007cites this paper
• Complications of AlphaCor Keratoprosthesis: A Clinicopathologic Report

  2007influential citation
• Keratoprosthesis: Current Techniques

  2006cites this paper
• Results from the multicenter Boston Type 1 Keratoprosthesis Study.

  2006cites this paper
• Progress in the development of a corneal replacement: keratoprostheses and tissue-engineered corneas

  2006cites this paper
• AlphaCor: Clinical Outcomes

  2006cites this paper
• Microkeratome assisted deep lamellar keratoprosthesis

  2006cites this paper
• Histology of AlphaCor Skirts: Evaluation of Biointegration

  2005cites this paper
• Keratoprosthesis: the Dohlman-Doane device.

  2005cites this paper